Editas Medicine EDIT
NASDAQ EDIT
$2.60 +0.01 (+0.19%)
As of: Sep 30, 2026 · 10:09 AM EDT

Editas Medicine (EDIT) EV to FCF (2017)

Updated

Editas Medicine's EV to FCF was 34.44 in Q2 2017, up 60.5% from the prior quarter.

Analysis

Editas Medicine (EDIT) EV to FCF (2017) Analysis & Trends

On a trailing twelve-month basis, Editas Medicine's EV to FCF was -35.70 through Jun 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Editas Medicine 234.09 Mn -477.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 34.44
Mar 31, 2017 21.46
API Access

Editas Medicine EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=EDIT&period=max&api_key=YOUR_API_KEY